Is now the time to get into crypto? Many investors may be looking to get into the space for the first time as the regulatory outlook improves.

The market regime may continue to shift in response to easing rates, potentially serving as a catalyst for SMIDcap and mid-cap companies. The rate cut cycle is expected to provide more relief for smaller and more leveraged companies needing more access to capital markets than larger companies.

The S&P 500 finished the week ending November 22 with strong gains, up 1.68% from last Friday. The index closed 0.53% away from a record high and is now up 25.86% year-to-date.

The U.S. Food and Drug Administration has approved BridgeBio's drug for a rare and deadly heart condition, the company said on Friday, making it the first new treatment in a market dominated by Pfizer's blockbuster Vyndaqel.

The US FDA has approved BridgeBio's new drug, Attruby, for treating transthyretin amyloid cardiomyopathy (ATTR-CM), a rare heart condition, marking a significant milestone for the company and introducing competition in a market previously dominated by Pfizer.

Waldencast plc. (NASDAQ:WALD ) Q3 2024 Earnings Conference Call November 21, 2024 8:30 AM ET Company Participants Allison Malkin - Investor Relations, ICR Michel Brousset - Founder and Chief Executive Officer Manuel Manfredi - Chief Financial Officer Conference Call Participants Jonna Kim - TD Cowen Dana Telsey - Telsey Advisory Group Sydney Wagner - Jefferies Susan Anderson - Canaccord Genuity Linda Bolton Weiser - D.A.

A New York state judge ruled Thursday (Nov. 21) that SiriusXM must change its subscription cancellation policies and pay unspecified damages. Justice Lyle Frank found that the company's policies violate the federal Restore Online Shoppers' Confidence Act, Reuters reported Friday (Nov. 22).

In the closing of the recent trading day, ChargePoint Holdings, Inc. (CHPT) stood at $1.15, denoting a +1.77% change from the preceding trading day.

Compared to crypto, stock multiples don't look outrageous. But in the past, rising bond yields and rich stock multiples have led to irrational exuberance and problems.

Volkswagen sees no chance of avoiding layoffs and plant closures in order to cut 4 billion euros ($4.2 billion) in costs, the brand's chief executive said in a newspaper interview, amid an escalating dispute with workers.